2025.11.17 – Methylphenidate 36 mg in the Netherlands: How to Keep ADHD Treatment Going

Key Takeaways

What this article is about
This article is about methylphenidate 36 mg and how to continue taking it safely and legally when living in the Netherlands, especially for people already treated for attention deficit hyperactivity disorder (ADHD) elsewhere.

Why a Dutch prescription matters
Methylphenidate is a prescription-only stimulant medicine. In the Netherlands, it is normally prescribed and monitored by a Dutch general practitioner or specialist, and pharmacies are expected to dispense it only on the basis of a valid local prescription.

Foreign prescriptions and their limits
Prescriptions written in another European Union country can sometimes be formatted specifically for use abroad, but prescriptions issued outside the European Union, such as from Mexico, generally cannot be used directly at Dutch pharmacies to obtain controlled stimulant medicines.

Finding a doctor and a pharmacy
New residents are encouraged to register with a nearby general practice and to choose a local pharmacy. After a consultation, the doctor can decide whether to continue methylphenidate and send the prescription electronically to the pharmacy of choice.

Costs, insurance and availability
Methylphenidate, including prolonged-release 36 mg tablets, is widely available in the Netherlands. Public price portals and insurance rules indicate that these medicines are often reimbursed, but actual out-of-pocket costs depend on the health insurer’s policy and agreements with specific pharmacies.

Safety and supervision
Health authorities emphasise that methylphenidate should form part of a broader ADHD treatment plan, used under medical supervision, and never obtained from unregulated online sellers or taken without a prescription.

Story & Details

A treatment that should not be interrupted

Imagine someone already diagnosed with ADHD and stabilised on methylphenidate 36 mg each day. The medicine helps them concentrate at work or university, manage daily tasks and keep impulsive behaviour under control. They know the brand names often used in Europe – long-acting formulations such as Concerta, Medikinet controlled-release and equivalent prolonged-release tablets from generic manufacturers – and they know from experience that missing doses can quickly affect sleep, mood and performance.

Now picture that person moving to the Netherlands. The suitcase holds a supply of tablets and a prescription from their psychiatrist back home, perhaps in Mexico. The questions come quickly. Will it be possible to keep taking the same medicine. Will a foreign prescription be accepted. How does one find a doctor in a town such as Zwanenburg. Is it realistic to arrange everything online, or will there be a long waiting list before the first Dutch prescription is written.

What the medicines authority explains

The Dutch medicines authority, the Medicines Evaluation Board, provides a straightforward answer about the legal position. Methylphenidate is available in the Netherlands only on prescription. That prescription has to be written by a Dutch doctor, usually a general practitioner who knows the patient or a specialist working in mental-health care. Pharmacies expect to receive an electronic prescription from such a prescriber and will not normally dispense methylphenidate on the basis of a document from outside the national system.

The same authority points people to public information on how to choose and register with a general practitioner. These resources explain that every resident is expected to have a regular doctor, who keeps track of their health over time and acts as a gateway to other services. Once a general practitioner decides that methylphenidate is appropriate, they can enter the prescription into an electronic system and send it directly to the pharmacy that the patient nominates.

Behind these practical details sits a broader role. The Medicines Evaluation Board grants marketing authorisations for medicines through the national procedure and monitors their safety once on the market. Its public materials make clear that safe use is just as important as initial approval, especially for medicines like stimulants that act on the central nervous system.

Why a foreign prescription is not enough

The question about whether a Mexican prescription could be used in the Netherlands highlights the way international rules work. Within the European Union, a prescription written in one member state can, under certain conditions, be recognised in another. Doctors can issue a specific form of prescription intended for use abroad, called a cross-border prescription, and pharmacies in other member states can often accept it if all the required information is present and the medicine is authorised locally.

This framework, however, is designed for prescriptions that move within the European Union and the wider European Economic Area. It does not extend automatically to prescriptions written in countries outside that area. A Dutch pharmacy asked to dispense controlled stimulant medication on the basis of a prescription from Mexico, or from many other non-European nations, would be operating outside that framework and would usually decline to do so.

For people who arrive with a supply of methylphenidate and a foreign prescription, this means that the safe route is to treat the foreign document as medical history rather than as a ticket to new refills. It can be shown to the Dutch doctor as evidence of previous treatment and dose, but it does not replace the need for a local consultation and a fresh prescription.

Travelling with existing medication

Another aspect of the journey concerns the tablets already in the suitcase. Dutch government information on travelling with medicines explains that most medicines can be brought into the country for personal use if the traveller can show that they are needed. However, medicines that fall under narcotics legislation, including certain ADHD treatments, require additional documentation. Travellers may need certificates based on international agreements, and they are often advised to carry medicines in original packaging, alongside a statement from the prescribing doctor.

These rules are not meant to make life difficult for patients but to manage the risks associated with substances that can be abused. For someone depending on methylphenidate 36 mg, they underline the importance of planning ahead, checking the rules before travel and making sure that supplies do not run out before a new doctor has been found.

How to find a doctor

Finding a new general practitioner can feel daunting, but Dutch information sites for residents and newcomers break the task into manageable steps. They explain that each practice has a defined catchment area and that people usually register with a practice close to where they live. Many practices now publish their registration policies online, including whether they are open to new patients, what information is required and how to request an introductory conversation.

These introductions are more than administrative formalities. They give patients a chance to describe their medical history, current medicines and expectations, and they give the doctor a chance to explain how the practice works. A person already using methylphenidate 36 mg can bring written summaries from their previous doctor, details of dose and schedule, and if possible, diagnostic reports confirming ADHD. This helps the new doctor evaluate whether to continue the same treatment, adjust it or refer to a psychiatrist for more detailed assessment.

For someone living in a town like Zwanenburg, regional and municipal health pages list nearby practices and provide contact details. In many parts of the country there are also online general-practice services that offer video consultations and digital intake, which can be useful when local practices are full or when someone prefers to start the process remotely.

Choosing a local pharmacy

Once registered with a general practitioner, the next step is to choose a pharmacy. In Dutch neighbourhoods, pharmacies are often found close to general practices or in small shopping areas near residential districts. Patients can tell their doctor which pharmacy they would like to use, and this preference is then recorded in their file so that prescriptions can be sent to the right place automatically.

Methylphenidate 36 mg, including long-acting formulations, is widely stocked by community pharmacies in the Netherlands. If a particular brand is not available on a given day, the pharmacy can often offer an equivalent generic product with the same active substance, strength and release characteristics. Pharmacists are also in a position to explain how the tablets should be taken, what side effects to watch for and what to do if a dose is missed.

Costs, insurance and availability

The cost of methylphenidate in the Netherlands is shaped by a mixture of national price regulation and agreements between health insurers and pharmacies. Public price portals list the official prices of different strengths and formulations, including prolonged-release 36 mg tablets, and indicate which of them fall within standard reimbursement schemes.

In practice, this means that many people with basic Dutch health insurance pay little or nothing extra for their ADHD medicine beyond any general deductible that applies to all prescription drugs. However, details vary between insurers, and sometimes between pharmacies that have different contracts. It is therefore wise to ask the pharmacy or the insurer directly how methylphenidate will be reimbursed and whether specific brands are preferred.

Safety, supervision and the wider debate

The story of a single patient trying to stay on treatment is part of a larger picture. European and Dutch health bodies have reviewed methylphenidate and similar stimulants and have concluded that, when used correctly, they can bring clear benefits for people with ADHD. At the same time, they stress that treatment should be embedded in a broader programme that may include psychological support, behavioural strategies and educational adjustments.

Public-health agencies have warned about the risks of taking methylphenidate without medical supervision, whether to stay awake longer, to cram for exams or simply out of curiosity. Side effects can include palpitations, rises in blood pressure, insomnia, loss of appetite and changes in mood. There is also concern about the impact on people with underlying heart conditions or psychiatric vulnerabilities. By keeping prescribing within the framework of regular care, with check-ups and clear agreements between doctor, patient and pharmacy, the Dutch system aims to make sure that the benefits of methylphenidate are realised while the risks are monitored.

Conclusions

A clear route forward

For someone already using methylphenidate 36 mg who is moving to the Netherlands, the practical route is now easier to see. The foreign prescription and treatment history are valuable as background information, but the key step is to register with a Dutch general practitioner, share that history in an honest and detailed way and agree on a plan for continued ADHD care. If the doctor decides that ongoing methylphenidate treatment is appropriate, a local prescription can be issued and sent electronically to a chosen pharmacy.

Balancing access and caution

This approach does more than follow rules for their own sake. It connects the person to a local healthcare system that can respond when situations change. A general practitioner can adjust the dose, monitor side effects, involve specialists when needed and help with related issues such as sleep, anxiety or study stress. Pharmacies, in turn, help ensure that the right formulation and strength are dispensed consistently. When each part of the system plays its role, a powerful medicine like methylphenidate 36 mg becomes not just a tablet in a box, but one element in a safer, more coherent plan for living with ADHD.

Sources

Official information on medicines and the Dutch regulator
Medicines Evaluation Board (CBG-MEB) – English-language overview of how medicines are authorised and monitored in the Netherlands:
https://english.cbg-meb.nl/
Background information on marketing authorisation for human medicines via the national procedure:
https://english.cbg-meb.nl/sections/marketing-authorisation-medicines-for-human-use

Understanding Dutch healthcare and general practice
Thuisarts and its English companion information for patients, explaining how general practice works and how to choose a general practitioner:
https://www.thuisarts.nl/dutch-healthcare/choosing-gp
https://www.thuisarts.nl/dutch-healthcare/planning-introductory-appointment-gp
https://www.thuisarts.nl/dutch-healthcare
https://huisartsenzorgoudeijssel.nl/thuisarts-nl-vertaald-thuisarts-nl-translated/

Rules for medicines, travel and controlled substances
Dutch government information on bringing medication into the country and on certificates required for medicines that fall under narcotics legislation:
https://www.government.nl/topics/medicines/question-and-answer/can-i-take-my-medication-abroad
https://www.netherlandsworldwide.nl/travel-netherlands/taking-medication-netherlands
https://www.government.nl/topics/travelling-outside-the-netherlands/question-and-answer/what-do-i-need-if-i-take-my-medication-outside-the-netherlands

European rules on prescriptions across borders
European Commission guidance on presenting a prescription in another EU country and on the use of cross-border prescriptions:
https://europa.eu/youreurope/citizens/health/prescription-medicine-abroad/prescriptions/index_en.htm

Clinical and safety information on methylphenidate and ADHD medication
Overview of reports and guidance on methylphenidate use in adults from the Netherlands Pharmacovigilance Centre:
https://www.lareb.nl/knowledge/filepreview?id=44786&p=1422
Article discussing methylphenidate for adults with ADHD and insurance coverage considerations:
https://www.ge-bu.nl/en/artikel/methylfenidaat-voor-adhd-bij-volwassenen-placebo-of-nocebo
Dutch national public-health report on improper use of methylphenidate and associated risks:
https://www.rivm.nl/en/news/improper-use-of-methylphenidate

Educational and practical resources on ADHD
Guidance from an ADHD advocacy organisation on travelling internationally with ADHD medication:
https://chadd.org/adhd-weekly/know-before-you-go-international-travel-with-adhd-medications/
Practical guide from a paediatric hospital on ADHD in school-age children and the role of stimulant medication:
https://www.childrenshospital.org/sites/default/files/2024-05/adhd-guide-middle-school.pdf

YouTube educational video
An educational video from Boston Children’s Hospital explaining how stimulant medication, including methylphenidate, is used in ADHD treatment and why careful monitoring is important:
https://www.youtube.com/watch?v=zpwtLM7XLOw

Appendix

Attention deficit hyperactivity disorder (ADHD)
A neurodevelopmental condition marked by persistent patterns of inattention, hyperactivity and impulsivity that interfere with work, study or relationships. Symptoms can include difficulty sustaining focus, restlessness, acting without thinking and problems with organisation or time management.

Cross-border prescription
A prescription written in one European Union country specifically so that it can be used in another member state. It contains standardised information about the prescriber, the patient and the medicine, making it easier for a pharmacy abroad to dispense the correct product safely.

Dutch general practitioner
A community-based doctor who provides first-line medical care, keeps an overview of the patient’s health history and usually acts as the main prescriber for long-term treatments such as ADHD medication, referring to specialists when needed.

Dutch Medicines Evaluation Board
The national authority responsible for assessing medicines for human and veterinary use, granting marketing authorisations through the national procedure and promoting the safe and effective use of medicines in everyday practice.

Methylphenidate
A central nervous system stimulant commonly used in the treatment of ADHD. It is available in immediate-release and prolonged-release forms, including 36 mg tablets, and is classified as a prescription-only medicine due to its potency and potential side effects.

Prescription-only medicine
A medicine that may be supplied only on the order of an authorised prescriber, such as a doctor, because it requires professional supervision, careful dosing or monitoring for adverse effects and is not considered safe for unsupervised self-medication.

Thuisarts and GPinfo
Public information platforms created and supported by Dutch general-practice organisations, offering accessible explanations about health conditions and about how the healthcare system in the Netherlands works for both residents and newcomers.

Zwanenburg
A town in the Netherlands that here serves as an example of a typical community where residents register with nearby general practices and collect their prescriptions at local pharmacies that operate under national rules for medicines such as methylphenidate.

2025.11.17 – Eleventh Human Resources and Entrepreneurs Congress in Santa Fe

Key Takeaways

This article is about the eleventh Human Resources and Entrepreneurs Congress held in Santa Fe, an event designed to unite leadership, resilience, finance, and modern people strategy into a single day of learning and connection.
The program took place on 7 November 2024, from 08:00 to 17:00, with both in-person attendance and live streaming so professionals across the region could join.
The agenda brought together voices on leadership grounded in optimism, resilience and personal development, finance for entrepreneurs, and new paradigms in human resources, framed by a special segment highlighting women who have transformed local industries.
The structure blended ideas with access, encouraging participants to exchange insights and build relationships that last beyond the event itself.

Story & Details

Opening tone

The event was introduced with a clear call to explore a gathering that promised to reshape how professionals understand human resources, leadership, and entrepreneurial practice. The invitation framed the day as a concentrated opportunity for learning, inspiration, and connection.

A one-day structure

The congress followed a straightforward schedule from 08:00 to 17:00, offering keynote talks, thematic sessions, and natural pauses designed for conversation. The hybrid model allowed both on-site and remote participants to follow the full program seamlessly.

Place

Santa Fe, Argentina — the capital city of the province of Santa Fe in the country’s northeast — served as the host. The congress took place at the Centro de Eventos Mutual Jerárquicos, a multi-purpose venue located within the urban area and surrounded by hotels, restaurants, and straightforward transport routes. Its location made it easy for both local and regional participants to arrive, engage in the full program, and return home comfortably within the same day.

Themes that shaped the day

Four central themes structured the congress. Leadership and optimism explored how tone and attitude influence team performance. Resilience and personal development highlighted the ability to recover, adapt, and continue growing. Finance for entrepreneurs connected financial decisions to long-term business sustainability. Emerging HR paradigms addressed the changing nature of culture, skills, and organizational expectations in a shifting professional landscape.

Women changing the game

A signature segment highlighted regional women who have reshaped their industries through determination, vision, and local impact. Guided by a biomedical engineer and academic director specializing in women’s leadership, this panel added depth, authenticity, and a grounded view of leadership as lived experience.

The value of connection

Throughout the day, the congress emphasized networking. Conversations in hallways, breaks, and digital chat spaces provided fertile ground for shared insights, collaboration ideas, and professional support. These interactions gave the event its lasting resonance, often extending its influence far beyond the formal sessions.

Local roots and broader relevance

Although firmly anchored in Santa Fe, the event reflected global shifts in leadership and human resources, particularly the move toward more empathetic, adaptive, and people-centered approaches. The congress became a meeting point where local perspectives aligned with worldwide professional conversations.

Conclusions

The eleventh Human Resources and Entrepreneurs Congress in Santa Fe delivered a full day shaped by leadership, resilience, finance, and modern people strategy. Its hybrid format, regional grounding, and mix of expert voices created an environment where ideas flowed naturally into practical insight.
As participants returned to their daily work, many carried forward conversations, contacts, and reflections that continued to influence their teams and ventures. A congress built for one day left impressions meant to last.

Sources

Official page for the Eleventh Human Resources and Entrepreneurs Congress: https://integrhalconsultora.com.ar/novedades/11-congreso-recursos-humanos-emprendedores/
Venue information (Centro de Eventos Jerárquicos): https://jerarquicos.com/centro-de-eventos/
Why you should make attending HR conferences a priority: https://globalconference.ca/why-you-should-make-attending-human-resource-conferences-a-priority/
3 Keys to elevating HR through networking (SHRM): https://www.shrm.org/enterprise-solutions/insights/3-keys-to-elevating-hr-through-networking
How HR conferences are shaping the future of leadership (UNLEASH): https://www.unleash.ai/how-hr-conferences-are-shaping-the-future-of-leadership-key-takeaways/
YouTube – The Explainer: What It Takes to Be a Great Leader (Harvard Business Review): https://www.youtube.com/watch?v=LU84BFFqKvI

Appendix

Congress
A professional gathering built around talks, conversations, and thematic sessions that explore shared interests in fields such as human resources and entrepreneurship.

Human resources
A discipline focused on people strategy, including recruitment, development, performance, and workplace culture.

Leadership
The act of guiding individuals and teams toward meaningful goals through clarity, empathy, and direction.

Networking
An ongoing process of forming professional relationships that support knowledge exchange, collaboration, and opportunity.

Resilience
The ability to face challenges, recover after difficulty, and continue developing with stability and purpose.

Streaming
Real-time broadcasting that allows participants to follow an event remotely through digital devices.

Venue
A physical location designed to host events, providing space, infrastructure, and services suited for large professional gatherings.

2025.11.17 – Methylphenidate 36 mg CR: How One Dutch Insurer Explains Access and Reimbursement

Key Takeaways

A medicine at the centre of daily life

Methylphenidate 36 mg in controlled-release form sits at the heart of this story. The focus is on how it can be prescribed, supplied and reimbursed under a Dutch health-insurance policy. This article is about understanding that pathway in clear, practical terms.

Privacy from employer scrutiny

The insurer explains that employers do not receive information about which medicines an insured person uses or claims for. Employment administration and medical claims are handled in separate channels, so treatment choices remain between the person, their prescribers and the insurer.

Dutch prescriptions as the legal basis

Even when someone arrives with a valid prescription from another country, medicines dispensed in the Netherlands must be based on a prescription written by a Dutch general practitioner or a Dutch medical specialist. The foreign prescription serves as important background, not as the legal basis for a Dutch pharmacy to dispense.

Reimbursement with conditions

On the national medicine-cost portal, several prolonged-release 36 mg methylphenidate products appear as reimbursable from basic insurance, usually with product-specific conditions and a modest personal contribution. When those conditions are met and the pharmacy sends the invoice directly to the insurer, there are no additional hidden costs beyond any deductible and listed co-payments.

Claims that travel through digital channels

For invoices that do not go straight from provider to insurer, the person can submit them through the My HollandZorg portal or the HollandZorg claims app. Standard claim forms, including English versions, help when claims are more complex, such as those involving care abroad.

Clinical judgement, not corporate instruction

The insurer makes an important distinction: it can explain coverage rules, but it cannot instruct doctors to prescribe methylphenidate 36 mg controlled release, nor can it guarantee that a prescription will be issued without mental-health consultation. Those are clinical decisions that remain with the prescribers.

Story & Details

A person who depends on one specific formulation

The story begins with someone who has long depended on methylphenidate 36 mg controlled release to manage symptoms consistent with attention-deficit/hyperactivity disorder. After moving under the umbrella of a Dutch health insurer, this person wanted to know whether that exact formulation could be continued, whether it would be reimbursed, and how to avoid unnecessary detours through unfamiliar services.

There was also anxiety about privacy: would the employer learn that stimulant medication was being used, especially when claims for a controlled substance passed through the insurance system? The insurer’s answer was straightforward. The employer does not see which medicines are involved. Health data sits in a different environment from payroll and contract administration, and data about treatment is shielded from workplace eyes.

Clarifying how claims are handled

The next concern was financial. How does a person actually get money back for the medicine if it is not billed automatically by a provider?

The insurer pointed to its digital backbone. My HollandZorg, the secure online environment, and the HollandZorg claims app are the main channels for submitting invoices that do not flow directly from providers to the insurer. When a contracted pharmacy or doctor sends invoices straight through, the insured person simply receives a statement explaining what was covered and whether any deductible or co-payment applies.

For more unusual situations, such as care abroad or providers without a direct billing link, the insurer offers printable claim forms. These forms, available in several languages including English, allow a person to attach original invoices and send everything in one package. Instructions on the insurer’s site explain how to handle invoices from other countries, which details must appear, and when a translation is required.

Checking coverage on a public register

Because methylphenidate 36 mg controlled release is a regulated medicine, reassurance about coverage matters. The insurer did something helpful: instead of giving only a yes-or-no answer, it directed attention to the national medicine-cost portal, Medicijnkosten.nl.

On that portal, each product has its own page. For several prolonged-release 36 mg tablets, these pages show the official product name, the average price per tablet and per package, and how much is reimbursed from basic insurance. They also indicate whether there is a personal contribution per tablet or per package. For one widely used generic product, the portal shows coverage with a modest personal contribution and explains that certain conditions apply. Other brands may carry different co-payments.

In everyday language, the insurer summed this up by saying that the medicine is covered when the conditions set by the government are met. If those conditions are satisfied and the pharmacy sends the invoice directly to the insurer, the person does not pay more than the standard deductible and any listed personal contribution attached to that product.

Why a Dutch prescription is still needed

Another key question was whether an existing prescription from abroad would be accepted as-is. The person had been treated and stabilised elsewhere and hoped to avoid repeating the entire diagnostic process.

The insurer explained the limit of what it can promise. In the Netherlands, a pharmacy needs a prescription from a Dutch general practitioner or a Dutch medical specialist in order to dispense methylphenidate. The earlier prescription from another country can be extremely useful as documentation, but it does not replace the need for a Dutch prescriber to take responsibility.

Behind that explanation lies a clinical and legal framework. Methylphenidate is a central nervous system stimulant, used primarily to treat attention-deficit/hyperactivity disorder. Medical resources from organisations such as Patient.info and the Mayo Clinic describe how it affects neurotransmitters, improves attention and reduces impulsivity, but also carries risks, including cardiovascular effects and potential misuse. Because of those risks, Dutch rules place it under a controlled-substances regime. Prescribers must monitor its use closely, adjust doses when necessary and check for contraindications, especially in adults.

In that context, the insurer cannot guarantee that a Dutch doctor will simply copy the previous prescription. Some doctors may be comfortable continuing a well-documented regimen; others may prefer fresh mental-health assessments.

Which doctors can prescribe this medicine?

The conversation naturally turned to who, exactly, can prescribe methylphenidate 36 mg controlled release. The insurer drew lines here as well.

In principle, both general practitioners and certain medical specialists are allowed to prescribe the medicine. However, each professional decides individually how far to go. Some are willing to initiate treatment themselves. Others insist that a psychiatrist or another mental-health professional carry out an assessment first. It is also common for prescribers to require documentation, such as prior diagnostic reports or treatment letters, before they consider taking over an existing regimen.

The insured person had already encountered these limits in practice. A telemedicine provider, MoviDoctor, had previously explained that it could not prescribe controlled stimulant medicines at all. This led to a new question: would walk-in services aimed at short-term visitors, such as Amsterdam Tourist Doctors, have the authority and willingness to prescribe methylphenidate 36 mg controlled release during an appointment, or would they also insist on referral to mental-health specialists?

The insurer’s answer was cautious. It does not direct clinical decisions and cannot promise that any specific service will prescribe a controlled medicine. It can confirm which providers sit within its network, but whether a doctor signs a prescription remains a professional choice.

Using tools instead of recommendations

Because of this distinction, the insurer avoids naming individual doctors or pharmacies as “the right place” to obtain the prescription. Instead, it points to its Carefinder, an online search tool.

With Carefinder, a person enters the type of care needed and a location. The tool then shows which general practices, mental-health clinics and pharmacies are contracted, along with basic details such as addresses and sometimes patient ratings. This makes it possible to build a shortlist of potential prescribers and pharmacies while staying within the insurer’s network, even though the insurer does not endorse any one provider by name.

Once a compatible prescriber is found, that doctor can, if they judge it safe and appropriate, start or continue the prescription. The pharmacy, ideally one that is also contracted, can then order the specific 36 mg controlled-release product indicated in the prescription.

The question of stock and shortages

The person also wanted to know whether methylphenidate 36 mg controlled release would be easy to find in stock. Recent years have brought periodic shortages of ADHD medicines in several countries, and the prospect of running out is naturally distressing.

Here, the insurer was explicit about the limits of its information. It does not have access to real-time pharmacy inventory systems and cannot see which branches currently have methylphenidate 36 mg controlled release on the shelf. The only reliable way to know is to contact pharmacies directly, especially those identified as contracted through Carefinder.

This means that, alongside the administrative steps, there is a practical one: calling a few pharmacies, asking whether they stock the relevant brand and strength, and whether they can order it in if not.

Messages that frame the insurance journey

Alongside questions about medicines, there was confusion about a sequence of informational messages. The person had received three messages about the health-insurance policy: one welcoming them to the Dutch system, one explaining when the cover would end, and one describing what to do when medical care is needed. A fourth message was expected but had not yet arrived.

The insurer’s explanation was technical but important. These messages are generated by a system that sends them at intervals of roughly two weeks. Occasionally, one may be delayed or lost. In that event, it is possible to request that the missing information be provided again, without any impact on the validity of the insurance itself.

When treatment crosses borders

Because the person had been treated abroad and might need care outside the Netherlands again, questions about international coverage were inevitable.

HollandZorg’s public information explains that necessary care abroad can be reimbursed if it falls within the Dutch basic package and meets conditions for medical necessity. For urgent care, there are pages dedicated to explaining which bills can be submitted, how they are evaluated and what limits apply.

The European Health Insurance Card, available in digital form through My HollandZorg, plays a complementary role. When travelling temporarily within the European Union and certain neighbouring countries, this card helps local providers recognise that an insured person is entitled to medically necessary care under European coordination rules. Any remaining financial questions, including how ADHD medicines are reimbursed abroad, are handled through the same claim channels already described.

Learning more about treatment options

Underlying many of these questions is a desire to understand how doctors think about ADHD treatment. Without referring to any specific broadcast, educational material from institutions such as the Mayo Clinic shows how specialists use rating scales, medical history and functional assessments to diagnose attention-deficit/hyperactivity disorder and to decide when stimulant medicines like methylphenidate are appropriate.

These resources explain why prescribers remain cautious: they must weigh symptom relief against side effects, screen for heart problems or other risks, consider non-pharmacological interventions and remain alert to the possibility of misuse. For people who already depend on methylphenidate 36 mg controlled release, such explanations can help frame discussions with new doctors when moving between countries or health systems.

Conclusions

A structured but navigable pathway

For someone who relies on methylphenidate 36 mg controlled release, the Dutch health-insurance framework can look complex at first glance. Yet the structure becomes clearer when broken into its components.

Privacy is protected by design: employers do not see which medicines are used. Coverage is grounded in public information on the national medicine-cost portal, which shows how each product is reimbursed and whether any personal contribution applies. Claims can be handled through My HollandZorg, the claims app or standard forms, depending on whether providers bill directly.

Clinical decisions remain firmly in the hands of doctors. A Dutch general practitioner or medical specialist must decide whether it is appropriate to prescribe methylphenidate 36 mg controlled release, drawing on prior records and, when necessary, fresh mental-health assessments. Pharmacies can then dispense the medicine once a compatible product is in stock or ordered.

Bringing it all together

In the end, the pathway is demanding but workable. It asks a person to combine public information, digital tools like Carefinder and My HollandZorg, and conversations with prescribers and pharmacists. For those who depend on methylphenidate 36 mg controlled release to function day to day, understanding this landscape is not just a bureaucratic exercise; it is a way to keep treatment steady, secure and sustainable in a new health system.

Sources

Appendix

Carefinder (Zorgzoeker)

Carefinder is the insurer’s online search tool for health-care providers. It allows users to enter the type of care and a location, then displays nearby providers, indicates whether they are contracted and sometimes shows how other patients rate their experiences.

Controlled release

Controlled-release formulations of methylphenidate are designed to release the active substance gradually over several hours. They smooth out peaks and troughs in symptom control and often make once-daily dosing possible, but different brands can have different coverage rules and personal contributions.

Digital European Health Insurance Card

The digital European Health Insurance Card is an electronic card available in the insurer’s online portal. It confirms that the holder is covered for medically necessary care during temporary stays in other European countries and can be shown on a phone or printed out when needed.

General practitioner

A general practitioner is the main point of contact for non-emergency health problems in the Dutch system. This doctor keeps the overall medical record, decides when to treat directly, when to refer to specialists and, in many cases, whether to prescribe medicines such as methylphenidate.

Medicijnkosten.nl

Medicijnkosten.nl is the Dutch government’s official medicine-cost portal. It lets anyone search for medicines by name, see average prices, check whether products are reimbursed from basic insurance and find out whether a personal contribution applies.

Methylphenidate 36 mg controlled release

Methylphenidate 36 mg controlled release is a central nervous system stimulant used mainly to treat attention-deficit/hyperactivity disorder. In this strength and formulation, it is typically taken once daily, offering long-lasting symptom control while requiring careful monitoring because of side effects and misuse risks.

My HollandZorg

My HollandZorg is the secure online environment for insured people. It provides access to policy details, claim submissions, claim overviews and the digital European Health Insurance Card, and serves as the central hub for most interactions with the insurer.

Opium Act framework

The Opium Act framework is the Dutch legal structure that regulates certain controlled substances, including stimulant medicines such as methylphenidate. It sets rules for prescribing, dispensing and carrying these medicines, which is why prescribers and pharmacies follow strict procedures even when the treatment itself is routine.

2025.11.17 – A Short Survey With a Clear Purpose: How HollandZorg Asks for Feedback

Key Takeaways

A focused article about one invitation

This article is about a brief invitation from HollandZorg to share feedback on a recent contact, using a short customer satisfaction survey carried out by MarketResponse.

A four-minute request for insight

The text describes a simple request: take about four minutes to answer a questionnaire about a recent exchange, so that service can be improved and satisfaction can grow.

Separation between insurer and research firm

HollandZorg appears as the health insurer seeking feedback, while MarketResponse is presented as an independent market research company responsible for running the survey.

Professional standards in the background

MarketResponse is mentioned as a member of the Data & Insights Network, which signals that the work is meant to follow an industry code of conduct for research and statistics.

Clear guidance for questions and issues

Technical issues with the questionnaire are directed to a dedicated research email address, while questions about health insurance itself are pointed to HollandZorg’s own customer service.

Participation by choice, not pressure

The text underscores that participation is voluntary, pairing a “Share your feedback” button with an explicit option to skip taking part this time.

Story & Details

Setting the scene: after a recent exchange

The message begins by referring to a recent contact by email with HollandZorg. That opening line quietly anchors the whole piece: the organisation is not sending out a generic questionnaire, but responding to a specific, recent interaction. The feedback requested is clearly tied to that moment.

From there, the text moves quickly to purpose. HollandZorg explains that it continuously works to improve its services and explicitly connects this ambition to customer satisfaction. The survey is framed as one of the tools used to understand how people experience the service they receive.

The heart of the request: a four-minute questionnaire

At the core lies a simple proposal. Readers are invited to share their views by filling in a questionnaire that should take about four minutes to complete. The time estimate is important. It suggests a compact, focused set of questions rather than a long or intrusive form, making the request feel more manageable and respectful of the reader’s day.

A clearly signposted call to action encourages people to “Share your feedback.” This element functions as the entry point into the survey, turning a general appeal into a practical next step that is easy to follow.

Roles and responsibilities: who does what

A key feature of the text is the way it separates roles. HollandZorg is the insurer whose service is being evaluated, but the research itself is carried out by MarketResponse. MarketResponse is presented as an independent market research company, which reassures readers that their answers are being handled by a specialist third party rather than by the insurer alone.

The message notes that MarketResponse is a member of the Data & Insights Network, a professional association that issues a code of conduct for research and statistics. By mentioning this membership, the invitation hints at the existence of shared professional standards on topics such as data handling, privacy and transparency, without going into technical details.

Help, support and the right channels

The text is careful about directing questions to the right place. Anyone who encounters technical problems while completing the questionnaire, or who has questions about the survey itself, is asked to contact MarketResponse directly using the institutional email address listed in the text.

Questions about health insurance, however, are not supposed to go to the research firm. Instead, the message instructs readers to contact HollandZorg’s own customer service. This preserves a clear distinction between research support and policy support and reduces the risk that someone will send personal insurance questions to the wrong organisation.

A gentle closing and an explicit opt-out

The tone in the closing lines remains low-key and appreciative. HollandZorg expresses the hope that readers will share their feedback and thanks them for any participation. Immediately alongside this, there is a short sentence offering an alternative: those who would rather not take part “this time” can simply choose to skip.

That small detail matters. It underlines that the survey is an invitation, not an obligation. Readers are given both a path to participate and a path to decline, with no suggestion that saying no carries any consequence. The end result is a piece of communication that invites, explains and reassures, while allowing people to decide freely whether they want to spend those four minutes.

Conclusions

A modest gesture with a clear structure

Taken as a whole, the text offers a neat example of how an insurer can ask for feedback without overwhelming its audience. The request is small, time-bounded and clearly connected to a specific interaction. The work is entrusted to a specialist research firm, and a reference to a professional association suggests that recognised standards are in play.

Respect for time, choice and boundaries

Equally important is the respect shown for the reader’s time and autonomy. The four-minute estimate makes the commitment concrete, the separate channels for technical and insurance questions keep responsibilities clean, and the explicit opt-out line acknowledges that feedback is voluntary. In an era when surveys can feel constant and intrusive, this quiet clarity stands out. It leaves the reader with a sense that their voice is welcome, but that the final decision to speak up is entirely their own.

Sources

HollandZorg customer service and contact overview for private health insurance customers, including published phone numbers and online contact options:
https://www.hollandzorg.com/nl/particulier/klantenservice

HollandZorg contact page describing ways to get in touch with customer service, including telephone details and an online form:
https://www.hollandzorg.com/nl/particulier/klantenservice/contact

HollandZorg contact form page offering a route for questions and indicating service hours and language support:
https://www.hollandzorg.com/nl/particulier/klantenservice/contact/contactformulier

MarketResponse main site presenting the company as a data and insights agency focused on improving customer relationships and satisfaction:
https://marketresponse.nl/

MarketResponse Group English-language overview of insights-driven marketing and customer experience services:
https://marketresponsegroup.com/

Data & Insights Network page referencing the 2023 code of conduct for statistical research:
https://datainsightsnetwork.nl/advies-en-tools/gedragscode-2023/

Example explanation of a customer satisfaction survey from a public environmental agency channel on YouTube, illustrating how a public body invites and guides people to fill in a customer satisfaction survey:
https://www.youtube.com/watch?v=e4WZ24VfR0Y

Appendix

Customer satisfaction programme

An ongoing effort by an organisation to measure and improve how satisfied people are with its services, typically using repeated surveys tied to real interactions and using the results to refine processes, communication and support.

Customer satisfaction survey

A structured set of questions designed to capture how people experienced a service, often asking them to rate aspects such as clarity, friendliness, speed and overall satisfaction, and sometimes leaving room for open comments.

Data & Insights Network

A professional association in the Dutch research and data field that issues a code of conduct and related guidance for organisations conducting statistical and market research, including expectations around privacy, data security and transparent communication.

HollandZorg

A Dutch health insurer that offers health insurance products and provides customer support through published phone numbers, forms and other contact channels for people who have questions or need help with their coverage.

Independent market research company

A research organisation that operates separately from the client whose services are being evaluated and is hired to design, conduct and analyse surveys so that feedback is collected and interpreted with professional distance.

MarketResponse

A data and insights agency that helps organisations understand customers and other stakeholders by gathering and analysing opinions and experiences, including through customer satisfaction and customer experience research.

Opt-out link

A short, clearly worded line in a message that gives people the option to decline an invitation with a single click, in this context allowing readers to skip participation in the survey “this time” without explanation.

Research contact address

An email address provided specifically for survey-related questions or technical problems, used to ensure that people taking part in a study know exactly where to turn if something is unclear or does not work as expected.

2025.11.17 – Methylphenidate 36 mg in the Netherlands: How to Continue Your ADHD Treatment After Moving

Key Takeaways

This article is about Methylphenidate 36 mg

This article explains how people already taking Methylphenidate 36 mg abroad can continue their treatment safely and legally after moving to the Netherlands.

A Dutch prescription is always required

A prescription from another country, such as Mexico, cannot be used directly at a Dutch pharmacy. A Dutch doctor must issue a new prescription before Methylphenidate 36 mg can be dispensed.

Your GP is usually the starting point

Most people begin by registering with a General Practitioner (GP). With a clear letter from the psychiatrist who started the treatment, many GPs are willing to continue prescribing Methylphenidate 36 mg, although some prefer to involve a Dutch psychiatrist first.

Brands are widely available

Long-acting Methylphenidate 36 mg is available in the Netherlands under several names, including Mylan, Xiromed, TEVA, and Concerta. Once a Dutch prescription exists, it can be sent to a pharmacy of your choice, and you can phone in advance to ask whether a specific brand is in stock.

Costs are partly covered by insurance

ADHD medication with methylphenidate is generally reimbursed from the basic health insurance package. Branded options such as Concerta often include a capped personal contribution, which can reach around 250 euros per year before further costs are taken over by the insurer.

Controlled-medicine rules shape the process

Methylphenidate is treated as a controlled substance in the Netherlands. Only licensed Dutch doctors can prescribe it, and pharmacies follow strict procedures when dispensing it. A detailed letter in English from your current psychiatrist helps doctors assess whether and how to continue your existing regimen.

Story & Details

Arriving with an established ADHD treatment

Imagine arriving in the Netherlands with life already running on the steady rhythm of Methylphenidate 36 mg. Concentration has improved, routines are in place, and the current dose works. The question comes quickly: can the existing prescription from Mexico simply be presented at a Dutch pharmacy?

The reality is more formal. Dutch pharmacies must work with prescriptions written by doctors who are authorised to practise in the Netherlands. Foreign prescriptions, even when clinically sound, serve as medical background rather than documents that can be used to supply a controlled medicine.

Why a new prescription is needed

Methylphenidate is subject to strict drug-control legislation in the Netherlands. That framework governs who may prescribe it, how it is dispensed, and how it may be carried across borders. For ongoing treatment inside the country, the prescriber must be a Dutch GP or psychiatrist. A foreign prescription shows what has been tried and what works, but it cannot replace a local prescription.

In practice, the first step for someone who has just moved is to register with a nearby GP. During the first consultation, bringing a thorough letter from the original psychiatrist makes a real difference. That letter ideally states the ADHD diagnosis, the current Methylphenidate 36 mg dose, the duration of treatment, previous medications, and any relevant side effects or comorbid conditions.

How Dutch GPs and psychiatrists handle continuity

Responses among GPs vary. Some are comfortable continuing an established ADHD treatment when they receive a clear and recent psychiatric letter and when the clinical course looks stable. Others are more cautious because methylphenidate is controlled, because they did not supervise the original work-up, or because practice policy asks for a Dutch specialist’s confirmation.

Several outcomes are common:

  • A GP may agree to continue prescribing Methylphenidate 36 mg in the same dose, with periodic reviews.
  • The GP may prescribe for a short bridging period while arranging a referral to a psychiatrist for a more detailed assessment.
  • The GP may prefer not to prescribe at all and instead refer the patient directly to a Dutch psychiatrist or mental-health service.

Alongside the regular route through insured care, some independent psychiatrists offer brief online consultations specifically for people who are already on a stable dose of methylphenidate. In one example, an interview plus prescription was quoted at 160 euros, to be paid privately and not reimbursed by insurance, while consultations with the GP were covered. For anyone considering this path, it is wise to confirm fees and what is included before booking.

What happens at the pharmacy

Once a Dutch doctor has decided to prescribe, attention turns to brands and supply. In the Netherlands, Methylphenidate 36 mg appears in several formulations. Pharmacists may dispense generic prolonged-release tablets from companies such as Mylan, Xiromed, or TEVA, or they may supply branded extended-release products like Concerta.

The prescription is usually sent electronically to a pharmacy selected by the patient. For those living in or near cities such as Amsterdam or towns like Zwanenburg, most local community pharmacies can either supply Methylphenidate 36 mg from stock or order it quickly. Because availability of particular brands can vary from one location to another, calling the pharmacy before collecting the medicine helps avoid surprises. The pharmacy team can check which products are available, whether a generic will be substituted, and if any brand must be specially ordered.

Insurance, contributions, and annual caps

Dutch basic health insurance covers many prescription medicines, including standard ADHD treatments based on methylphenidate. The details become more nuanced with long-acting or branded versions such as Concerta. Those products are often subject to a regulated personal contribution. National rules limit this contribution for prescription medicines to a maximum amount per calendar year, frequently cited as 250 euros. Once this ceiling is reached for eligible medicines, further costs for those products are generally covered.

The result is a mixed picture. Someone using Methylphenidate 36 mg in a generic form may see little or no extra charge beyond the standard deductible that applies to much Dutch healthcare. Someone dependent on a specific branded product may pay part of the price personally until the personal-contribution cap is reached. Supplementary insurance policies sometimes provide additional cover for these contributions, so reading the small print of the policy or contacting the insurer directly is useful.

Living with a controlled ADHD medicine in a new system

Because methylphenidate is a controlled substance, its path through the healthcare system is more closely tracked than that of many other medicines. Pharmacies may ask patients to use one main branch consistently, may dispense smaller quantities at a time, and may require photo identification at collection. These measures support safe use and reduce the risk of the medicine being misdirected or misused.

Travel adds another layer. People who need to carry Methylphenidate 36 mg when crossing borders often require official documentation that confirms it is prescribed for personal medical use. For travel to and from the Netherlands, that paperwork is usually based on a valid Dutch prescription, underscoring once again how important it is to arrange local follow-up promptly after a move.

Conclusions

A structured handover, not a fresh start

For someone already well adjusted to Methylphenidate 36 mg, relocating to the Netherlands does not erase the progress that has been made. It does, however, require a structured handover into a new legal and medical environment. The existing prescription and psychiatric letter form the backbone of that handover, guiding Dutch doctors as they decide how to continue care.

Working with Dutch rules for long-term stability

Success depends on cooperation between patient, GP, psychiatrist, and pharmacist. A Dutch prescription is the gateway to treatment, GPs and psychiatrists shape how it is used, and pharmacies supply the actual medicine while respecting controlled-drug rules. Insurance cushions much of the financial burden, even when certain long-acting products carry a capped contribution. With clear documentation and realistic expectations, continuing Methylphenidate 36 mg in the Netherlands becomes less a struggle and more a careful, manageable transition.

Sources

Government information on what to arrange when moving to the Netherlands, including how to find and register with a GP, is available here:
https://www.government.nl/topics/immigration-to-the-netherlands/question-and-answer/what-do-i-need-to-arrange-if-i%E2%80%99m-moving-to-the-netherlands

Guidance on travelling with medicines subject to drug-control rules, including ADHD medication containing methylphenidate, can be found on the Netherlands Worldwide portal:
https://www.netherlandsworldwide.nl/travelling-with-medicines

Details of which medicines are reimbursed, how personal contributions work, and how national caps on these contributions are applied are explained (in Dutch) on the official medicine-costs platform:
https://www.medicijnkosten.nl/

Consumer-focused explanations of reimbursement for ADHD medicines, including the way contributions apply to long-acting methylphenidate products such as Concerta, are provided by the Dutch Consumers’ Association:
https://www.consumentenbond.nl/zorgverzekering/vergoedingen/adhd-medicijnen

Practical information on finding and using community pharmacies across the Netherlands, including address details and opening hours, can be searched on the national pharmacy site:
https://www.apotheek.nl/vind-een-apotheek

For a clear, practical explanation of how stimulant medicines such as methylphenidate work in ADHD, this educational video provides an accessible overview:
https://www.youtube.com/watch?v=WpwaFfV_Rkg

Appendix

Concerta

A branded, prolonged-release form of methylphenidate used to treat ADHD. It delivers the active substance gradually over the day and, in the Netherlands, typically involves a regulated personal contribution on top of basic insurance reimbursement.

General practitioner (GP)

A community-based doctor who provides first-line medical care, coordinates referrals to specialists, and often manages long-term conditions such as ADHD once diagnosis and initial treatment have been established.

Methylphenidate

A central nervous system stimulant commonly prescribed for ADHD. It increases the activity of certain brain chemicals involved in attention and impulse control and is available in short-acting and long-acting formulations, including 36 mg prolonged-release tablets.

Opium Act

The main Dutch law governing controlled substances, including certain prescription medicines such as methylphenidate. It sets out rules for prescribing, dispensing, storage, and transport of these substances, both within the country and when crossing borders.

Pharmacy

A licensed healthcare provider that dispenses prescription medicines, offers advice on their safe use, and maintains records for controlled drugs. In the Netherlands, patients are normally registered with a preferred local pharmacy that handles most of their prescriptions.

Psychiatrist

A medical specialist in mental health who can diagnose disorders such as ADHD, prescribe medications including controlled substances, and provide or coordinate psychological and pharmacological treatment plans.

Prescription

A formal instruction issued by a licensed doctor that authorises a pharmacy to dispense a specific medicine in a defined strength, dose, and quantity. For methylphenidate in the Netherlands, this document must be written by a Dutch prescriber to be valid at a Dutch pharmacy.

Reimbursement

The way health insurance pays for part or all of the cost of medicines and other services. In the Dutch system, reimbursement for ADHD medicines can combine full coverage for some products with capped personal contributions for others, within the limits set by national rules.

2025.11.16 – Youth Ambassadors Take the Lead at the Internet Society Symposium

Key Takeaways

Central focus
This article is about the Youth Ambassador Program Symposium organized by the Internet Society, a gathering that celebrates and showcases the work of emerging Internet leaders.

Who is involved
Each year, the Internet Society selects fifteen young, passionate participants for its Youth Ambassador Program, giving them training, mentoring, and a platform to influence the future of the Internet.

When it happens
The symposium takes place on a Thursday at 13:00 Coordinated Universal Time (UTC), which is 14:00 in the Europe/Amsterdam time zone, and is designed as a live, interactive event.

What will be discussed
Youth Ambassadors lead four major conversations: misinformation, empowering youth in discussions about artificial intelligence, digital safety skills, and digital inclusion.

How people can follow
The event is delivered in English and offers simultaneous interpretation into Spanish and French, making it accessible to a broad international audience.

Story & Details

A capstone for a whirlwind journey
The Youth Ambassador Program is built around a simple but powerful idea: if young people are given serious training, real responsibility, and a global stage, they can help shape the Internet in meaningful ways. Over the course of the program, fifteen selected participants move through what organizers describe as a whirlwind learning and development journey. They deepen their understanding of Internet governance, sharpen their advocacy and leadership skills, and work closely with peers and mentors who care about an open, secure, and inclusive Internet.

The symposium is the moment when that journey becomes visible to the wider world. It is a public space where Youth Ambassadors present what they have been working on, test their ideas against real questions, and connect with others who share their concerns and ambitions.

Four youth-led conversations

At the heart of the symposium are four themed conversations, each led by Youth Ambassadors themselves:

  • Misinformation
    Ambassadors explore how misleading or false information spreads online, how it affects communities, and which practical strategies can strengthen resilience. The discussion looks at digital literacy, the role of platforms, and community-based responses that do not sacrifice fundamental rights.
  • Empowering youth in conversations around artificial intelligence
    This strand focuses on how artificial intelligence is designed, governed, and rolled out in daily life, and asks where young people fit in those decisions. Ambassadors examine ways to move youth from being just users or data points to being active contributors in debates about fairness, transparency, and accountability in AI systems.
  • Digital safety skills
    Here the emphasis is on everyday skills that make online participation safer. The discussion ranges from basic security habits to more advanced practices, such as managing digital identities, recognizing manipulation or harassment, and building supportive networks that help people protect one another online.
  • Digital inclusion
    The final conversation looks at who is left out of digital life and why. Youth Ambassadors explore barriers such as connectivity gaps, cost, language, accessibility needs, and limited digital skills. They share ideas on how communities, policymakers, and organizations can close these gaps so that everyone has a fair chance to benefit from the Internet.

An open invitation to participate

Although the symposium is built around the achievements of Youth Ambassadors, it is not a closed circle. Attendees are invited to listen closely, ask questions, and bring their own experience to the table. The goal is not to deliver finished answers, but to create a shared space where people working on similar issues can compare approaches and spark new collaborations.

Because the event offers simultaneous interpretation into Spanish and French alongside English, participants from different regions can follow the discussions in real time and contribute in their preferred language. That linguistic openness mirrors the broader aim of the program: to ensure that the next generation of Internet leaders reflects the diversity of the communities they serve.

Conclusions

A platform for new leadership
The Youth Ambassador Program Symposium shows what happens when young people are trusted as leaders rather than treated only as beneficiaries. They bring concrete proposals, hard questions, and the energy needed to keep debates about the Internet grounded in real life.

From ideas to shared action
By centering conversations on misinformation, artificial intelligence, digital safety, and digital inclusion, the symposium keeps its focus on the issues that most directly affect how people experience the Internet. Participants leave with new perspectives, useful contacts, and practical ideas they can adapt in their own communities.

Why it is worth paying attention
In a landscape where decisions about the Internet often feel distant and technical, this gathering stands out as a reminder that the future of the network is also a matter of human relationships and public voice. Paying attention to Youth Ambassadors today is one way of seeing where Internet governance may be headed tomorrow.

Sources

Internet Society — Youth Ambassador Program (program description and yearly selection of fifteen participants):
https://www.internetsociety.org/policy-programs/youth-ambassadors/

Internet Society — Youth Ambassador Program Symposium 2023 (example of symposium format and themes):
https://www.internetsociety.org/events/youth-ambassador-program-symposium-2023/

Internet Society — Events listing, including Youth Ambassador Program symposium and related gatherings:
https://www.internetsociety.org/events/

YouTube — Internet Society: “Youth Ambassador 2023: Daniele Turra” (short profile illustrating the kind of youth leadership highlighted by the program):
https://www.youtube.com/watch?v=VLnlZQduUqQ

Appendix

Artificial intelligence (AI)
Artificial intelligence refers to computer systems that can perform tasks which typically require human intelligence, such as recognizing patterns, making predictions, or taking decisions based on data. In the context of the symposium, AI is discussed as a technology that should be shaped with meaningful youth participation.

Digital inclusion
Digital inclusion describes the effort to ensure that everyone can access and benefit from the Internet. It involves affordable connectivity, appropriate devices, relevant content, and training so that people can use online tools confidently and effectively.

Digital safety skills
Digital safety skills are practical abilities that help people protect themselves and others online. They include managing passwords, recognizing scams or harassment, controlling privacy settings, and understanding the risks and responsibilities that come with sharing information.

Internet Society
The Internet Society is a global, non-profit organization that works to keep the Internet open, globally connected, secure, and trustworthy. It supports community projects, technical standards, policy engagement, and fellowship programs such as the Youth Ambassador Program.

Misinformation
Misinformation is information that is false or misleading, shared without a clear intent to deceive. At the symposium, it is examined in terms of how it spreads, how it affects trust, and how communities can respond without undermining free expression.

Simultaneous interpretation
Simultaneous interpretation is a form of live language translation in which interpreters render what is being said into another language in real time, allowing participants who speak different languages to follow and join the same event.

Youth Ambassador Program (YAP)
The Youth Ambassador Program is an initiative of the Internet Society that selects a small group of young people each year for training, mentoring, and participation in high-level Internet governance spaces. It culminates in a symposium where their work and ideas are shared with a wider audience.

2025.11.16 – WhatsApp’s New Screen-Sharing Warning Is a Quiet but Timely Safeguard

Key Takeaways

What changes now. WhatsApp has begun showing an alert if you start to share your screen with someone who isn’t in your contacts. The prompt is meant to make you pause before exposing sensitive information.

Why it matters. Screen sharing can reveal one-time codes, banking details, passwords, and notifications. Scammers often push for a quick share “to help fix a problem” and then capture what appears on your display.

How to spot legitimacy. Official product and safety notices arrive from the verified WhatsApp information channel. The header displays the WhatsApp name with a verification badge and a line indicating that only WhatsApp can send messages there.

What to do. Treat screen sharing like handing over your wallet: only with people you know and trust. Never display one-time codes, banking numbers, or password managers while sharing.

Story & Details

A small alert with big intent. The new on-screen nudge appears when you attempt to share your display with an unfamiliar contact. It’s a momentary checkpoint designed to interrupt the classic high-pressure playbook used in support-impersonation and investment scams. By asking you to confirm, it cuts into the “act now” urgency that social engineers rely on.

Why scammers love screens. A single shared view can expose authentication codes, account dashboards, or even a glimpse of a password manager. Once a fraudster sees a six-digit code or navigates you to a payment screen, the damage can be immediate. The alert is not a silver bullet, but it raises the friction right where it counts.

Reading the cues of an official notice. The security message described here arrived from WhatsApp’s own announcement channel. Two cues stand out: the verified badge next to the brand name, and the notice that messages are sent only by WhatsApp in that thread. It’s a broadcast lane for product and safety updates, not a place to reply.

Everyday hygiene that still wins. Keep two simple rules front and center. First, never share your screen with strangers or anyone rushing you. Second, keep sensitive items out of view: one-time codes, banking portals, tax documents, and password vaults. If a caller claims to be from a company, hang up and contact the company through a trusted path you find yourself.

The broader push against scams. The warning joins a slate of efforts across messaging apps—context cards, safety overviews, and takedowns of large networks—to slow the wave of social-engineering schemes. Independent reporting and official help pages underscore the same theme: slow down, verify, and keep control of your data.

Conclusions

A better default. The most effective defenses are often small, well-placed pauses. This is one of them. It doesn’t replace judgment, but it buys a breath before sharing something intimate: your screen.

A calmer cadence online. If a request feels rushed or oddly urgent, stop. Close the call, confirm the identity on your terms, and keep codes and accounts out of view. The alert is the nudge; the decision is yours.

Sources

Appendix

Announcements-only chat. A one-way thread used for product and safety updates. Messages come from the service; recipients can’t reply in that space.

Official WhatsApp account. The brand-run information channel identified by the verified badge and standard branding, used to distribute official notices.

Safety overview. An interstitial screen that summarizes context and risks before you engage with a potentially unsafe action or conversation.

Screen sharing. A feature that broadcasts your device’s display during a call; it can reveal notifications, codes, and account pages if not used carefully.

Social engineering. Manipulative tactics—urgency, authority, fear—used to pressure someone into risky actions like sharing screens or revealing codes.

Verification badge. A visible checkmark that indicates WhatsApp has verified the account’s identity and authenticity for official communications.

2025.11.16 – When Biology Stretches the Calendar: Late Fatherhood, Science, and a 2023 Case

Key Takeaways

A slow fade, not a cliff. Medicine recognizes no fixed cut-off for male fertility. Sperm production continues across the lifespan, while average quality declines gradually.

What changes with age. By about forty, studies show downward trends in semen volume and sperm motility; by the mid-fifties, markers of DNA damage typically rise.

Treatment patterns. Assisted-reproduction registries and cohort studies often report lower success rates and more miscarriages as paternal age advances, though findings vary by design and by egg source.

Extraordinary claims need evidence. No verified record shows natural paternity past one hundred; the oldest documented legal father was ninety-two.

Mechanism matters. Research from Harvard Medical School reported that most new germline mutations originate in fathers and increase with paternal age—one path to elevated genetic risks in offspring as men grow older.

Story & Details

A late chapter. Robert De Niro (born August 17, 1943) welcomed a daughter, Gia Virginia Chen-De Niro, in April 2023 at age seventy-nine. Public announcements and interviews on U.S. network programs sketched a portrait of steady contentment rather than spectacle.

How they met. De Niro first met Tiffany Chen, a martial-arts instructor, while filming The Intern in 2015. They were seen together publicly in 2021, and their relationship has since moved into family life.

A simple rule. Accounts of his parenting style return to a plain idea: if children are not harming themselves or others, they deserve firm, consistent support.

Famous company. Late fatherhood is unusual, not unheard of. Recent high-profile examples include Al Pacino becoming a father at eighty-three, Mick Jagger at seventy-three, and Bernie Ecclestone at eighty-nine—each instance triggering the same public mix of fascination and debate.

Beyond headlines. Large reviews and open-access studies converge on a pattern: semen parameters trend downward with age and DNA fragmentation rises; clinical outcomes in assisted reproduction often ease downward with each decade, even after attempts to control for maternal age. The story is variability on top of trend.

Conclusions

Capability persists; probabilities shift. Many men can father children in later life, but averages move: semen volume and motility tend to fall from about forty onward, DNA damage markers climb by the mid-fifties, and assisted-reproduction success rates often taper with paternal decades. Extraordinary anecdotes aside, there is no verified case of natural paternity past one hundred. Mechanistic work from Harvard Medical School on paternal-age-linked mutations helps explain why several developmental risks rise with older fathers. The practical takeaway is calm and clear: biology stretches, yet it also keeps count.

Sources

Appendix

Advanced paternal age. A research label for higher paternal-age brackets—often forty, forty-five, or fifty and older—used to examine trends in fertility and child-health outcomes.

Assisted reproductive technology (ART). Clinical methods such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) that help achieve pregnancy; results can be influenced by both maternal and paternal age.

De novo mutation. A genetic change that appears for the first time in a child, not present in either parent’s somatic DNA; these mutations accumulate more rapidly in the male germ line as men age.

DNA fragmentation index (DFI). A laboratory measure of sperm with DNA breaks; higher values correlate with reduced fertility potential and, in several studies, higher miscarriage rates.

Motility and semen volume. Motility is the ability of sperm to swim effectively; volume is the amount of semen per ejaculation. Both show average age-related declines.

Paternal-age effect. The observed association between increasing paternal age and rising rates of de novo mutations and certain developmental risks in offspring.

2025.11.16 – A Small Bilingual Snapshot: 525 in Words, Plus Core Pronouns

Key Takeaways

Numbers in focus
A single number, 525, appears several times and is written out in two ways: “five hundred twenty five” and “vijfhonderdvijfentwintig.”

Core pronouns
Simple pairs link English and Dutch: I → ik, me → mij, we → wij.

Sound hints
Tiny prompts such as “ee” and “y” point to common trouble spots for beginners.

Story & Details

The number
The figure 525 stands at the center. It is repeated and once circled, as if to anchor a short study moment.

English wording
On the English side, the line reads “five hundred twenty five.” It is plain and direct, with no “and” between hundred and twenty.

Dutch wording
Next to it, Dutch shows “vijfhonderdvijfentwintig,” written as one long compound. It mirrors the English meaning: five hundred, five-and-twenty.

Letter cues
Two small notes stand alone: “ee” and “y.” They look like reminders. The first suggests attention to long vowels; the second flags a letter that behaves differently across the two languages.

Pronoun pairs
Three quick matches tie form to meaning: I → ik, me → mij, we → wij. Together they sketch subject, object, and plural basics many learners memorize early.

Conclusions

What it shows
This brief set of lines does a lot with very little. One number links both languages. Three pronouns give a first map of person and case. Two letter prompts nudge the ear. It’s simple, tidy, and useful—the kind of minimal study aid that keeps practice moving.

Sources

Reference sites

One verified video

Appendix

Dutch compound number word
“Vijfhonderdvijfentwintig” is the Dutch way to write 525 as one compound word.

EE
A short prompt to watch long vowel spelling and sound in practice words.

English number wording
“Five hundred twenty five” is the straightforward English phrasing of 525 without “and.”

ENG/NL labels
Simple headings that mark English and Dutch content side by side.

Menen het (unclear)
A faint note resembles “menen het.” Its meaning is uncertain here, so it is not interpreted further.

Numeral 525
The numeric anchor that ties the two spellings and all quick prompts together.

Pronoun mapping
Three pairs— I/ik, me/mij, we/wij—show basic subject, object, and plural forms at a glance.

Y
A reminder to watch the letter “y,” which can vary in use and sound between English and Dutch.

2025.11.16 – The Office Coffee Carafe That Wouldn’t Pour — And the Simple Twist That Fixes It

Key Takeaways

The complaint, in plain words. A frustrated user couldn’t pour coffee because the lid felt “complicated,” after trying to move it sideways and press it inward.

What the scene shows. A stainless-steel thermal carafe with a black lid and handle on a tidy desk, a small “coffee” label in Dutch, plus everyday office items nearby.

The mechanism at work. Most office thermal carafes use a threaded stopper or a pour-through design—opening by turning left (counter-clockwise), not by pulling.

The practical fix. Hold the lid, rotate it counter-clockwise a quarter to half turn to unlock or reach the pour position, then lift if removal is needed.

Safety first. Open slowly and point the spout away from you; hot-liquid pressure can cause sudden release and splashes.

Story & Details

Why it felt impossible.
Side-to-side wiggles and downward pressure are the right instincts for a press-fit lid, but not for a threaded stopper. In many office carafes, the stopper seals with a gasket and right-hand threads. That seal will not budge until it’s turned.

What the hardware is telling you.
The rounded, one-piece top and the rim near the handle are hallmarks of screw-on or pour-through lids. Some versions include a hidden lever or dome you press while pouring; others rely on aligning an internal channel with a partial turn.

The move that works.
Grip the lid, rotate left—usually just a quarter to half turn—until the stop releases. At that point, either pour directly (if it’s a pour-through design) or lift the lid free. When reinstalling, align the marks (if present), seat the lid, and turn right to lock.

When there’s still resistance.
If threads are stuck, warm the plastic around the stopper under hot tap water for a few seconds, then try the left turn again. Tiny expansions can break the stiction without forcing it. Avoid tools; they can crack plastic or deform gaskets.

Variants you might encounter.
Lever-stopper carafes: hold the handle, press the lever, and tilt to pour; release the lever to close. Twist-and-pour stoppers: a slight turn opens an internal path so you can serve without removing the lid. Easy-pour lids on some brewers pour with minimal adjustments.

Good habits for next time.
Pre-warm the carafe with hot water before brewing to reduce heat shock and keep coffee hotter. Rinse the pour path, and periodically deep-clean the lid assembly so dried coffee oils don’t glue threads or valves.

Conclusions

The shortest route to coffee. Turn left, don’t pry. A brief counter-clockwise twist unlocks most thermal carafe lids or sets them to pour; remove only if needed. Work slowly and away from your face, and the coffee finally flows—no wrestling, no spills.

Sources

Appendix

Counter-clockwise. The leftward rotation that loosens standard right-hand threads used on many carafe stoppers.

Lever stopper. A lid with a spring-loaded lever; pressing it opens the internal valve so liquid can pour, releasing it reseals the carafe.

Pour-through stopper. A twist-to-open design that aligns an internal channel with the spout, allowing pouring without removing the lid.

Thermal carafe. A vacuum-insulated container that maintains beverage temperature for hours; common in offices and drip brewers.

Threaded lid. A screw-on stopper that seals via threads and a gasket; it must be rotated to unlock or reach the pour position.

Vacuum lock. Temporary sticking caused by temperature changes and tight seals; gentle warming of the lid area can ease the first turn.

Design a site like this with WordPress.com
Get started